1-3 of 3
Meghan Higman
Close
Sort by
Journal Articles

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Hong Liu, MD, PhD, Theresa Hahn, PhD, Gregory Wilding, PhD, Adrienne Groman, Barbara Bambach, MD, Meghan Higman, MD, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD
Journal: Blood
Blood (2011) 118 (21): 4570.
https://doi.org/10.1182/blood.V118.21.4570.4570
Published: 2011
Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD
Journal: Blood
Blood (2010) 116 (21): 766.
https://doi.org/10.1182/blood.V116.21.766.766
Published: 2010
Journal Articles

Pentostatin: Efficacy in Refractory Chronic GVHD in Children.

David A. Jacobsohn, MD, ScM, Brittan Browning, MS, RD, Kimberly Thormann, RN, CRNP, Meghan Higman, MD, PhD, Michele L. Phelps, RN, Allen R. Chen, MD, PhD, Georgia B. Vogelsang, MD
Journal: Blood
Blood (2004) 104 (11): 2249.
https://doi.org/10.1182/blood.V104.11.2249.2249
Published: 2004